Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome - Related Studies

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

This study has been completed.

Study NCT00089765. Last updated on August 16, 2007. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Von Hippel-Lindau Syndrome

2	Additional conditions recognized in this trial
		Syndrome
		Von Hippel-Lindau Disease

3	More general conditions related to this trial
		Angiomatosis
		Cardiovascular Diseases
		Disease
		Nervous System Diseases
		Neurocutaneous Syndromes
		Pathologic Processes
		Vascular Diseases

4	Interventions listed in this trial
		Ranibizumab

5	Sponsors listed in this trial
		National Eye Institute (NEI)